Loading asset research
Decoy Therapeutics Inc. Common Stock
DCOYNasdaq · USD · StocksQuote as of · Exchange session not verified$2.67
-2.20%
Today
DCOY
Loading 1D prices…
Market cap
$1.7M
Volume
24.4K
52w high
$70.8052w low
$2.60Company profile
Decoy Therapeutics Inc. Common Stock
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company's IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs. It focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Houston, Texas.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Houston, TX, United States
Employees
11
Fiscal year end
1231
CIK
1615219
Session & valuation
Open$2.75
Previous close$2.73
Day high$2.78
Day low$2.60
30-day avg. volume26.4K
Outstanding shares655.2K
Diluted EPS-$129.10
Latest annual period
P/E (trailing)0.02
P/E (forward)-0.14
Price / book0.33
Beta0.56
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| RNAZTransCode Therapeutics Inc. Common Stock | $1.8M | $0.00 | — | -$52.59 | 0.00% | Unrated |
| JAGXJaguar Health Inc. Common Stock | $1.6M | $11.5M | -0.47% | -$22.97 | -1.57% | Unrated |
| VBIOValion Bio Inc. Common Stock | $2M | $0.00 | — | -$196.00 | +2.73% | Unrated |
| SHPHShuttle Pharmaceuticals Holdings Inc. Common Stock | $2.1M | $0.00 | — | -$7.16 | 0.00% | Unrated |
| PPCBPropanc Biopharma Inc. Common Stock | $2.1M | $0.00 | — | -$23.82 | -2.34% | Unrated |